Literature DB >> 23462064

Quantification and reduction of reflux during embolotherapy using an antireflux catheter and tantalum microspheres: ex vivo analysis.

Aravind Arepally1, James Chomas, Dara Kraitchman, Kelvin Hong.   

Abstract

PURPOSE: To demonstrate in a porcine model that reflux during embolotherapy can be relatively quantified (ie, as embolization efficiency) and that nontarget embolization can be eliminated by using an antireflux microcatheter.
MATERIALS AND METHODS: Renal artery embolization was performed with radiopaque tantalum microspheres (concentration of 1 g/20 mL) in three swine. Second-order right renal arteries (n = 3) underwent embolization with a 3-F antireflux catheter, and second-order left renal arteries (n = 3) underwent embolization with a 4-F end-hole catheter as a control. After embolization, kidneys were explanted and underwent micro-computed tomographic (microCT) imaging. Three-dimensional volumetric and multiplanar imaging of the kidneys was performed to assess vascular distribution. Digital Imaging and Communications in Medicine data were analyzed, with a threshold algorithm used to create binary images. The number of positive values in a region of interest in the target embolized tissue (upper pole or lower pole) and the nontarget adjacent tissue was determined, and embolization efficiency was calculated. Wilcoxon rank-sum statistical analysis was performed to compare nontarget embolization between infusion catheters.
RESULTS: All renal arteries underwent successful embolization with tantalum microspheres, with 20 mL (1 g) administered in all dose deliveries. MicroCT provided high-resolution visualization of the renal parenchyma at 70-μm resolution. In control renal arteries, a standard 4-F end-hole catheter had an embolization efficiency of 72%± 13. In experimental renal arteries, the antireflux microcatheter had an embolization efficiency of 99.9%± 1.0 (P< . 05).
CONCLUSIONS: A significant decrease in nontarget embolization (ie, reduction in reflux) was possible with an antireflux microcatheter compared with a conventional end-hole catheter.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23462064     DOI: 10.1016/j.jvir.2012.12.018

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  6 in total

1.  The Impact of Injection Distance to Bifurcations on Yttrium-90 Distribution in Liver Cancer Radioembolization.

Authors:  Amirtahà Taebi; Nursultan Janibek; Roger Goldman; Rex Pillai; Catherine T Vu; Emilie Roncali
Journal:  J Vasc Interv Radiol       Date:  2022-03-15       Impact factor: 3.682

2.  Realistic boundary conditions in SimVascular through inlet catheter modeling.

Authors:  Amirtahà Taebi; Selin Berk; Emilie Roncali
Journal:  BMC Res Notes       Date:  2021-05-31

3.  Surefire infusion system versus standard microcatheter use during holmium-166 radioembolization: study protocol for a randomized controlled trial.

Authors:  Andor F van den Hoven; Jip F Prince; Rutger C G Bruijnen; Helena M Verkooijen; Gerard C Krijger; Marnix G E H Lam; Maurice A A J van den Bosch
Journal:  Trials       Date:  2016-10-25       Impact factor: 2.279

4.  End-hole Versus Microvalve Infusion Catheters in Patients Undergoing Drug-Eluting Microspheres-TACE for Solitary Hepatocellular Carcinoma Tumors: A Retrospective Analysis.

Authors:  Joseph J Titano; Aaron M Fischman; Arnav Cherian; Madeline Tully; Lance L Stein; Louis Jacobs; Raymond A Rubin; Michael Bosley; Steve Citron; Dean W Joelson; Roshan Shrestha; Aravind Arepally
Journal:  Cardiovasc Intervent Radiol       Date:  2019-01-11       Impact factor: 2.740

5.  Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System® for the treatment of hepatocellular carcinoma.

Authors:  Alexander Y Kim; Shelby Frantz; Pranay Krishnan; Danielle DeMulder; Theresa Caridi; George Emmett Lynskey; James B Spies
Journal:  PLoS One       Date:  2017-09-01       Impact factor: 3.240

6.  Approaches for safe transarterial chemoembolization of multifocal hepatocellular carcinoma with retrograde flow in a retroportal artery.

Authors:  Souheil Saddekni; Amr Soliman Moustafa; Sherif Moawad; Khalid Mahmoud; Basant Farouk Hamed; Ahmed Kamel Abdel-Aal
Journal:  Radiol Case Rep       Date:  2017-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.